Amorphical Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.amorphical.com
Evaluating the Safety and Efficacy of AMOR-1 As a Treatment for Hypocalcemia Associated with Hypoparathyroidism in Adults
Phase 2
Not yet recruiting
- Conditions
- Hypoparathyroidism
- Interventions
- Drug: AMOR-1Drug: Crystalline Calcium Carbonate
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT06547151
- Locations
- 🇮🇱
Barzilai Medical Center, Ashkelon, Israel
🇮🇱Soroka Medical Center, Beer Sheva, Israel
🇮🇱Kaplan Medical Center, Rehovot, Israel
A Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism
Not Applicable
Terminated
- Conditions
- Hypoparathyroidism
- Interventions
- Dietary Supplement: amorphous calcium carbonate
- First Posted Date
- 2024-03-01
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06288490
- Locations
- 🇮🇱
Rambam Health Care Campus, Haifa, Israel
Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.
Phase 1
Completed
- Conditions
- Covid19
- Interventions
- Drug: AMOR 18 Powder & InhalationDrug: Placebo
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT04900337
- Locations
- 🇮🇱
Ziv MC, Tsefat, Israel
🇮🇱Tel-Aviv Sourasky MC, Tel Aviv, Israel
🇮🇱Shamir MC, Be'er Ya'aqov, Israel
The Effect of Amorphous Calcium Carbonate (ACC) Treatment on Function and Welfare in Late-stage Solid Cancer Subjects
Phase 1
Terminated
- Conditions
- Oncology
- Interventions
- Drug: Amorphous Calcium Carbonate (ACC) - Amor
- First Posted Date
- 2018-07-10
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 11
- Registration Number
- NCT03582280
- Locations
- 🇮🇱
Hadassah Ein Carem, Jerusalem, Israel
Improving Function,Welfare of Late-stage Cancer Subjects by ACC
Phase 1
Terminated
- Conditions
- Solid Malignancies, With or Without Lung Metastases
- Interventions
- First Posted Date
- 2017-02-20
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03057314
- Locations
- 🇮🇱
Meir, Kfar Saba, Israel
Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC
Phase 1
Withdrawn
- Conditions
- Castrate Resistant Prostate Cancer With Bone Metastasis
- Interventions
- Drug: Amorphous calcium carbonateOther: Placebo
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Amorphical Ltd.
- Registration Number
- NCT02864784
- Locations
- 🇮🇱
Soroka Medical Center, Beer sheva, Israel
A Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures
Phase 1
Terminated
- Conditions
- Distal Radius Fractures
- Interventions
- Other: PlaceboDietary Supplement: Amorphous calcium carbonate
- First Posted Date
- 2013-05-22
- Last Posted Date
- 2016-08-04
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT01859468
- Locations
- 🇮🇱
Barzilai Medical Center, Ashkelon, Israel
🇮🇱Bazilai Medical Center, Ashkelon, Israel
A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients
Phase 1
Completed
- Conditions
- Hypoparathyroidism
- Interventions
- Dietary Supplement: amorphous calcium carbonateDietary Supplement: crystalline calcium supplements
- First Posted Date
- 2013-03-20
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Amorphical Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT01815021
- Locations
- 🇮🇱
Rambam Health Care Campus, Haifa, Israel
Analgesic Effects of the Gastrolith, in Osteoporotic Patients Suffering From Recent Skeletal Pain Caused by Vertebral Fractures
Not Applicable
Withdrawn
- Conditions
- Osteoporosis
- Interventions
- Dietary Supplement: GastrolithOther: Placebo
- First Posted Date
- 2011-12-01
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Amorphical Ltd.
- Registration Number
- NCT01482858
- Locations
- 🇮🇱
Clalit Health Services - South District, Be'er Sheva, Israel
🇮🇱Soroka Medical Center, Be'er Sheva, Israel
🇮🇱Rambam Medical Center, Haifa, Israel
© Copyright 2025. All Rights Reserved by MedPath